ArticleMolecular therapy. Advances2026

Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophy.

Gretchen Thomsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.